NO890261D0 - Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.

Info

Publication number
NO890261D0
NO890261D0 NO890261A NO890261A NO890261D0 NO 890261 D0 NO890261 D0 NO 890261D0 NO 890261 A NO890261 A NO 890261A NO 890261 A NO890261 A NO 890261A NO 890261 D0 NO890261 D0 NO 890261D0
Authority
NO
Norway
Prior art keywords
preparation
procedure
therapeutic active
tetrahydropyridine derivatives
active tetrahydropyridine
Prior art date
Application number
NO890261A
Other languages
English (en)
Other versions
NO890261L (no
Inventor
Gerhard Walther
Karl-Heinz Weber
Werner Stransky
Franz Josef Kuhn
Erich Lehr
Enzio Mueller
Gunter Schingnitz
Helmut Ensinger
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO890261D0 publication Critical patent/NO890261D0/no
Publication of NO890261L publication Critical patent/NO890261L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
NO89890261A 1988-01-21 1989-01-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater. NO890261L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3801659A DE3801659A1 (de) 1988-01-21 1988-01-21 Tetrahydropyridin - derivate

Publications (2)

Publication Number Publication Date
NO890261D0 true NO890261D0 (no) 1989-01-20
NO890261L NO890261L (no) 1989-07-24

Family

ID=6345698

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89890261A NO890261L (no) 1988-01-21 1989-01-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.

Country Status (22)

Country Link
US (1) US5422353A (no)
EP (1) EP0325263B1 (no)
JP (1) JP2967989B2 (no)
KR (1) KR890011841A (no)
AT (1) ATE80873T1 (no)
AU (1) AU615978B2 (no)
CS (1) CS274508B2 (no)
DD (1) DD283378A5 (no)
DE (2) DE3801659A1 (no)
DK (1) DK24889A (no)
ES (1) ES2043896T3 (no)
FI (1) FI890277A (no)
GR (1) GR3005838T3 (no)
HU (1) HU202495B (no)
IL (1) IL89015A (no)
NO (1) NO890261L (no)
NZ (1) NZ227662A (no)
PL (1) PL157626B1 (no)
PT (1) PT89500B (no)
SU (1) SU1628856A3 (no)
YU (1) YU12189A (no)
ZA (1) ZA89424B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0551963A3 (en) * 1986-12-17 1993-09-01 Glaxo Group Limited Use of heterocyclic derivatives for the manufacture of medicaments
JPH01233270A (ja) * 1988-03-14 1989-09-19 Shionogi & Co Ltd ピロリンおよびテトラヒドロピリジン誘導体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT287711B (de) * 1968-06-25 1971-02-10 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen 1-Alkyl-1,2,5,6-tetrahydro-3-pyridylmethyl-carbonsäureestern sowie deren Säureadditionssalzen und quaternären Ammoniumverbindungen
US4467095A (en) * 1969-02-10 1984-08-21 Fmc Corporation Anticholinergic compounds

Also Published As

Publication number Publication date
FI890277A0 (fi) 1989-01-19
PL277260A1 (en) 1989-10-16
YU12189A (en) 1991-04-30
PT89500B (pt) 1994-03-31
ZA89424B (en) 1990-09-26
EP0325263A1 (de) 1989-07-26
NO890261L (no) 1989-07-24
EP0325263B1 (de) 1992-09-23
PL157626B1 (en) 1992-06-30
DK24889A (da) 1989-07-22
AU2861589A (en) 1989-07-27
ATE80873T1 (de) 1992-10-15
HU202495B (en) 1991-03-28
JP2967989B2 (ja) 1999-10-25
IL89015A (en) 1993-02-21
JPH01224361A (ja) 1989-09-07
DK24889D0 (da) 1989-01-20
IL89015A0 (en) 1989-08-15
DD283378A5 (de) 1990-10-10
PT89500A (pt) 1989-10-04
ES2043896T3 (es) 1994-01-01
US5422353A (en) 1995-06-06
AU615978B2 (en) 1991-10-17
GR3005838T3 (no) 1993-06-07
NZ227662A (en) 1991-04-26
CS39189A2 (en) 1990-08-14
KR890011841A (ko) 1989-08-22
FI890277A (fi) 1989-07-22
SU1628856A3 (ru) 1991-02-15
DE3801659A1 (de) 1989-07-27
CS274508B2 (en) 1991-04-11
HUT50122A (en) 1989-12-28
DE58902310D1 (de) 1992-10-29

Similar Documents

Publication Publication Date Title
NO875082D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer.
NO894630D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO880182L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater.
NO902411D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer.
NO165922C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av hexahydro-8-hydroxy-2,6-methano-2h-kinolizin-3-(4h)-on og beslektede forbindelser.
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO171909C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater
NO165071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
NO166130C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-pyridonderivater.
NO891723L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO171211C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
NO306468B1 (no) Nye fosfolipid-derivater, deres fremstilling, legemiddel inneholdende derivatene og derivatenes anvendelse
NO893768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2,7-diamino-1,2,3,4-tetrahydronaftalenderivater.
NO890724D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO166715C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cytorodin s derivater.
NO890519D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater.
NO890328D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 4-amino-2,3-disubstituert-6,7-dihydro-5h-1-pyrindinderivater.
NO170541C (no) Analogiframgangsmaate for framstilling av terapeutisk aktive 1,5-benzotiazepinderivater
NO170017C (no) Analogiframgangsmaate for framstilling av terapeutisk aktive 1,5-benzotiazepinderivater
NO921307D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,5-tritianderivater
NO890506D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kloranilin-derivater.